Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(20%)

Phase Distribution

Ph not_applicable
5
50%
Ph phase_2
1
10%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

60.0%

6 of 10 finished

Non-Completion Rate

40.0%

4 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(6)
Terminated(4)

Detailed Status

Completed6
Terminated2
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (16.7%)
N/A5 (83.3%)

Trials by Status

completed660%
terminated220%
withdrawn220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DEVICE
Total Trials
10